Use of trilostane for the treatment of pituitary‐dependent hyperadrenocorticism in a cat
2003
Skelly, B. J. | Petrus, D. | Nicholls, P. K.
Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use of the steroid synthesis inhibitor trilostane for the treatment of hyperadrenocorticism in a domestic shorthaired cat with pituitary‐dependent disease. Although trilostane was able to alleviate the severity of the clinical signs and was well tolerated, the cat subsequently died of renal failure secondary to a fungal infection of the urinary tract.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
Blackwell Publishing Ltd
其它主题
Dihydrotestosterone; Complications; Adrenocortical hyperfunction; Differential; 3-hydroxysteroid dehydrogenases; Renal insufficiency; Pituitary neoplasms; Sudden; Therapeutic use; Cat diseases; Administration & dosage; Male; Analogs & derivatives; Antagonists & inhibitors; Veterinary
语言
英语
注释
Journal article
Includes references
类型
Journal Article; Text
2024-02-28
MODS